Background illustration for clinical trials search

Paid Clinical Trials Nashville

Discover 1,248 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

for
Ovarian Cancer, Endometrial Cancer,
Location: Nashville TN, Fairfax VA, Orlando FL, Irving TX,
Sponsor: ArriVent BioPharma, Inc.

Sex: Female

Age: 18+

Code: NCT07755436

Phase1, Recruiting

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

for
Biliary Tract Cancer, Breast Cancer, Cervical Cancer,
Location: Denver CO, Nashville TN, Houston TX, Miami FL,
Sponsor: ModeX Therapeutics, An OPKO Health Company

Sex: All

Age: 18+

Code: NCT06239194

Phase1, Phase2, Recruiting

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

for
Solid Malignancies, Hematologic Malignancies
Location: Nashville TN, Louisville KY, Atlanta GA, Charlotte NC,
Sponsor: Immunome, Inc.

Sex: All

Age: 18+

Code: NCT06823167

Phase1, Recruiting

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

for
Non Small Cell Lung Cancer
Location: Nashville TN, Chattanooga TN, Durham NC, Bronx NY,
Sponsor: Agennix

Sex: All

Age: 18+

Code: NCT00706862

Phase3, Recruiting

Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

for
Hormone Receptor-positive Breast Cancer,
Location: Nashville TN, Detroit MI, Fairfax VA, Tampa FL,
Sponsor: Ellipses Pharma

Sex: Female

Age: 18+

Code: NCT05573126

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Nashville TN, Louisville KY, Omaha NE, New York City NY,
Sponsor: Avistone Biotechnology Co., Ltd.

Sex: All

Age: 18+

Code: NCT06046495

Phase1, Recruiting
New

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

for
Small Cell Lung Cancer (SCLC ),
Location: Nashville TN, St Louis MO, Dallas TX, Houston TX,
Sponsor: Moonlight Bio, Inc

Sex: All

Age: 18+

Code: NCT07488923

Phase1, Recruiting

Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma

for
Lymphoma
Location: Nashville TN
Sponsor: Favrille

Sex: All

Age: 18+

Code: NCT00258336

Phase2, Recruiting

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

for
Ovarian Cancer, Endometrial Cancer, Germ Cell Tumor,
Location: Nashville TN, Atlanta GA, Indianapolis IN, Columbus OH,
Sponsor: Xencor, Inc.

Sex: All

Age: 15+

Code: NCT06276491

Phase1, Recruiting

Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease

for
Non-Small Cell Lung Cancer
Location: Nashville TN, Birmingham AL, Stuart FL, Boston MA
Sponsor: Precision Therapeutics

Sex: All

Age: 18+

Code: NCT01450553

Recruiting

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

for
Aortic Stenosis
Location: Nashville TN, Birmingham AL, Cincinnati OH,
Sponsor: Medtronic Cardiovascular

Sex: All

Age: 18 - 70+

Code: NCT06777368

Recruiting

A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors

for
Colorectal Cancer, Triple Negative Breast Cancer,
Location: Nashville TN, Atlanta GA, Columbus OH, Hot Springs AR,
Sponsor: OncXerna Theraputics, Inc.

Sex: All

Age: 18+

Code: NCT05453825

Phase2, Recruiting

PEN-866 in Patients With Advanced Solid Malignancies

for
Carcinoma, Endometrial Adenocarcinoma, Neoplasms,
Location: Nashville TN, Denver CO, Germantown TN, Greenville SC,
Sponsor: Tarveda Therapeutics

Sex: All

Age: 18+

Code: NCT03221400

Phase1, Phase2, Recruiting

Yoga for Pediatric Tension-Type Headache

for
Headache
Location: Nashville TN
Sponsor: Matthew Morris

Sex: All

Age: 13 - 18

Code: NCT03166358

Recruiting

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

for
Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD
Location: Nashville TN, Asheville NC, Carmel IN, Hickory NC,
Sponsor: Adverum Biotechnologies, Inc.

Sex: All

Age: 50+

Code: NCT07482176

Phase3, Recruiting

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

for
Clear Cell Renal Cell Carcinoma
Location: Nashville TN, Louisville KY, Atlanta GA, Cincinnati OH,
Sponsor: Xencor, Inc.

Sex: All

Age: 18+

Code: NCT05433142

Phase1, Recruiting

Survey Study for Pain Management, Wound Care, Scar Care or UDT

for
Pain, Scars, Wounds, Urinary Drug Testing
Location: Nashville TN
Sponsor: Rahm Foundation

Sex: All

Age: 18+

Code: NCT02195063

Recruiting
Active & Responsive

A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC

for
Primary Sclerosing Cholangitis (PSC)
Location: Nashville TN, Iowa City IA, Baltimore MD, Seattle WA
Sponsor: LISCure Biosciences

Sex: All

Age: 18 - 70+

Code: NCT06699121

Phase2, Recruiting
Active & Responsive

A Study of YL201 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Nashville TN, St Louis MO, Chapel Hill NC, Ann Arbor MI,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT05434234

Phase1, Phase2, Recruiting
Featured

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

for
Alopecia Areata
Location: Murfreesboro TN, Indianapolis IN, Mason OH,
Sponsor: AbbVie

Sex: All

Age: 12 - 63

Code: NCT06012240

Phase3, Recruiting